Related Experiment Video
Updated: Sep 29, 2025
The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
[Biomarkers in renal cancer.]
José Miguel Giménez-Bachs1, Antonio S Salinas-Sánchez1
1Servicio de Urología. Complejo Hospitalario Universitario de Albacete. Albacete. España.
Abstract:
The natural history of renal cell canceris unpredictable and despite the increased knowledgeof this disease, the incidence has been increasing in recent years. Renal cancer represents a tumor withsignificant mortality and efforts to understand its behaviorhavenot yet translated into a decrease in mortality.In the study of renal cell cancer, the knowledge ofmolecular pathways is very important, since they arethe basis for the development of new therapies. Thisknowledge has made it possible to reclassify these tumorsand the current challenge is the search for biomarkersthat allow to establish an adequate diagnosisand prognosis and predict the response to a certaintype of treatment.In the present manuscript we carry out a review ofthe main markers studied and their potential value inrenal cell cancer.
Insights
Renal cell cancer remains unpredictable with increasing incidence. This review explores key molecular markers for improved diagnosis, prognosis, and targeted therapies in kidney cancer.
Area of Science:
- Oncology
- Molecular Biology
- Urology
Background:
- Renal cell carcinoma (RCC) exhibits unpredictable behavior, with rising incidence despite advancements in understanding the disease.
- Significant mortality associated with kidney cancer underscores the urgent need for improved diagnostic and therapeutic strategies.
- Current research focuses on understanding molecular pathways to develop novel treatments for RCC.
Purpose of the Study:
- To review the main molecular markers studied in renal cell cancer.
- To evaluate the potential value of these markers in diagnosis, prognosis, and predicting treatment response.
- To highlight the importance of molecular pathway knowledge for developing new RCC therapies.
Main Methods:
- Literature review of published studies on renal cell cancer molecular markers.
- Analysis of current research on the role of molecular pathways in RCC.
- Synthesis of information on diagnostic, prognostic, and predictive biomarkers for kidney cancer.
Main Results:
- Molecular pathway knowledge has enabled reclassification of renal cell tumors.
- Several key molecular markers have been identified and studied for their potential in RCC.
- The search for reliable biomarkers remains a critical challenge for personalized medicine in kidney cancer.
Conclusions:
- Understanding molecular pathways is crucial for advancing renal cell cancer treatment.
- Biomarkers are essential for accurate diagnosis, prognosis, and tailoring therapies for kidney cancer patients.
- Continued research into molecular markers holds promise for improving outcomes in renal cell carcinoma.
